Gary A. Lyons - Director at Eledon Pharmaceuticals, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
ELDN on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Gary A. Lyons since 06 Oct 2025

Reported holdings for Gary A. Lyons in Eledon Pharmaceuticals, Inc.

Form 4 holding Director

Eledon Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
150,437
Estimated value
$673,958
Report date
01 May 2023
Price
$4.48
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Gary A. Lyons in Eledon Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .